Phase 2 study of AB-SA01 in Staphylococcal infections patients with Chronic Rhinosinusitis

Trial Profile

Phase 2 study of AB-SA01 in Staphylococcal infections patients with Chronic Rhinosinusitis

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2017

At a glance

  • Drugs AB SA01 (Primary)
  • Indications Staphylococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Apr 2017 According to an AmpliPhi Biosciences media release, the US FDA has provided positive feedback on the company's previously submitted detailed development proposal to commence this trial.
    • 04 Jan 2017 According to an AmpliPhi Biosciences Corporation media release, company intends to initiate this study in the second half of 2017.
    • 09 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top